Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05174988 · ClinicalTrials.gov registry record · NA

Reducing Postoperative Bleeding After Hysterectomy Via Independent Closure of Vaginal Cuff Angles

A NA study of Patient Satisfaction and Postoperative Bleeding, sponsored by Texas Tech University Health Sciences Center, El Paso.

Completed
Registry status
NA
Development phase
117
Enrollment target
1
Study location

NCT05174988: Completed NA study of Patient Satisfaction and Postoperative Bleeding, sponsored by Texas Tech University Health Sciences Center, El Paso.

NCT05174988 is a NA study of Patient Satisfaction and Postoperative Bleeding that has completed, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 117 participants, below the 462-participant average among 20 other Patient Satisfaction trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05174988, a NA study of Patient Satisfaction and Postoperative Bleeding, has completed, sponsored by Texas Tech University Health Sciences Center, El Paso.

COMPLETED
Registry status
NA
Development phase
117 participants
Enrollment target
1
Study location

Study Summary

The investigators propose prospectively evaluating if adding separate sutures to the angles of the vaginal cuff before running barbed suture reduces the incidence of patient's perception of bleeding after surgery.

Primary Outcome

Pelvic pain scale from 0-10 assessed at postoperative visit, with 10 representing worse pain imaginable, and 0 representing no pain

Interventions

  • PROCEDURE Angle stitch

Study Locations (1)

Texas

  • Texas Tech University Health Scince Center El Paso - El Paso

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2022-01-31
Est. Completion 2023-08-07
Phase NA

What the finished NCT05174988 record still lists

NCT05174988 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 462-participant average among 20 other Patient Satisfaction trials with a reported enrollment target (75% lower).

The record links to 4 conditions, with Patient Satisfaction appearing as the primary indexed condition, and to 1 intervention - of which Angle stitch is the first listed.

NCT05174988 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05174988 about?

NCT05174988 is a clinical study titled "Reducing Postoperative Bleeding After Hysterectomy Via Independent Closure of Vaginal Cuff Angles". The investigators propose prospectively evaluating if adding separate sutures to the angles of the vaginal cuff before running barbed suture reduces the incidence of patient's perception of bleeding after surgery.

What is the current status of trial NCT05174988?

This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2022-01-31. Estimated completion is 2023-08-07.

What conditions does trial NCT05174988 study?

This clinical trial studies the following conditions: Patient Satisfaction, Postoperative Bleeding, Complications, Operative Time.

What interventions are being tested in trial NCT05174988?

The interventions under investigation include: Angle stitch (PROCEDURE).

Who is sponsoring clinical trial NCT05174988?

This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05174988 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patient Satisfaction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05174988's enrollment target sits among peer trials

117 10th of 20 higher than 11 of 20 other Patient Satisfaction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Patient Satisfaction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03539822 · 117 participants · Phase 1

    Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

  • NCT03786692 · 117 participants · Phase 2

    Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

  • NCT04479696 · 117 participants · NA

    Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

  • NCT04940585 · 117 participants · NA

    ROSE in Sunset Park

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05174988, the US trial registry maintained by the National Library of Medicine. NCT05174988 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.